These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8470853)

  • 21. [Chronic hepatitis: value of clinical and biological features in its differentiation].
    Antón Aranda E; López García C; Martí Cabané J; Tiberio López G
    Rev Esp Enferm Apar Dig; 1986 Dec; 70(6):503-6. PubMed ID: 3563013
    [No Abstract]   [Full Text] [Related]  

  • 22. Lipid lowering medication and hepatotoxicity.
    Kinnman N; Hultcrantz R
    J Intern Med; 2001 Sep; 250(3):183-5. PubMed ID: 11555121
    [No Abstract]   [Full Text] [Related]  

  • 23. [Morphological diagnosis of chronic hepatitis. Minimal requirements for histopathological referral].
    Guido M; Faa G
    Pathologica; 1998 Apr; 90(2):176-82. PubMed ID: 9619063
    [No Abstract]   [Full Text] [Related]  

  • 24. Combined nitrofurantoin toxicity to liver and lung.
    Reinhart HH; Reinhart E; Korlipara P; Peleman R
    Gastroenterology; 1992 Apr; 102(4 Pt 1):1396-9. PubMed ID: 1551546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Letter to the editor: Prediction of biochemical nonresolution in patients with chronic drug-induced liver injury: A large multicenter study.
    Tao X; Zhao Y; Chen L; Zeng M; Mi Y; Xu L
    Hepatology; 2022 Jul; 76(1):E13-E14. PubMed ID: 35112375
    [No Abstract]   [Full Text] [Related]  

  • 26. [Histological changes in viral hepatitis].
    Aguirre-García J; Ramos-Martínez E; Velasco-Avilés F
    Rev Gastroenterol Mex; 1982; 47(3):139-48. PubMed ID: 6085520
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clometacin, chronic active hepatitis and markers of autoimmunity].
    Lamouliatte H; Quinton A; Becouard Y; Delteil L
    Gastroenterol Clin Biol; 1982; 6(8-9):715-6. PubMed ID: 7129023
    [No Abstract]   [Full Text] [Related]  

  • 28. [Chronic active hepatitis secondary to drugs].
    Valencia Mayoral P; Vega Ramos B
    Rev Gastroenterol Mex; 1988; 53(3):185-92. PubMed ID: 3057577
    [No Abstract]   [Full Text] [Related]  

  • 29. [Chronic active hepatitis due to bendazac].
    Rodríguez Rodríguez E; Prieto de Paula JM; Cancelo Suárez P; Echevarría Iturbe C
    Rev Clin Esp; 1994 Aug; 194(8):657-8. PubMed ID: 7938854
    [No Abstract]   [Full Text] [Related]  

  • 30. Autoimmune hepatitis triggered by administration of an herbal medicine.
    Kamiyama T; Nouchi T; Kojima S; Murata N; Ikeda T; Sato C
    Am J Gastroenterol; 1997 Apr; 92(4):703-4. PubMed ID: 9128330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ashwagandha-Induced Liver Injury: Self-Reports on Commercial Websites as Useful Adjunct Tools for Causality Assessment.
    Weber S; Gerbes AL
    Am J Gastroenterol; 2021 Oct; 116(10):2151-2152. PubMed ID: 34187981
    [No Abstract]   [Full Text] [Related]  

  • 32. Drug-induced chronic liver disease, with emphasis on chronic active hepatitis.
    Seeff LB
    Semin Liver Dis; 1981 May; 1(2):104-15. PubMed ID: 7051296
    [No Abstract]   [Full Text] [Related]  

  • 33. Hazards of interferon therapy for HBV-seronegative chronic hepatitis.
    Vento S; Di Perri G; Garofano T; Cosco L; Concia E; Ferraro T; Bassetti D
    Lancet; 1989 Oct; 2(8668):926. PubMed ID: 2571851
    [No Abstract]   [Full Text] [Related]  

  • 34. Chronic active hepatitis due to hydroxymethylnitrofurantoin in a male patient.
    Baetens P; Ramboer C
    Acta Clin Belg; 1984; 39(2):85-91. PubMed ID: 6741394
    [No Abstract]   [Full Text] [Related]  

  • 35. [Chronic hepatitis caused by oxyphenisatin].
    Bercetche M; Pérez V; Avaginina A
    Medicina (B Aires); 1984; 44(1):59-63. PubMed ID: 6549524
    [No Abstract]   [Full Text] [Related]  

  • 36. Chronic active hepatitis in mice induced by 3-hydroxy-4-pyrone.
    Bhathal PS; Ho SL; Hegarty MP; Harris RL
    Experientia; 1984 Aug; 40(8):894-6. PubMed ID: 6468611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Acute toxic hepatitis: RUCAM application to drug-induced liver injury and its limitations].
    Ahn BM
    Korean J Hepatol; 2006 Mar; 12(1):1-4. PubMed ID: 16565601
    [No Abstract]   [Full Text] [Related]  

  • 38. [Chronic hepatitis with an acute presentation due to Ecstasy].
    Chaudier B; Oliver M; Coton T; Civatte M; Guisset M; Carré D; Debonne JM; Delpy R
    Gastroenterol Clin Biol; 2002 Jan; 26(1):103-4. PubMed ID: 11938056
    [No Abstract]   [Full Text] [Related]  

  • 39. Direct-Acting Antivirals for Chronic Hepatitis C: Can Drug Properties Signal Potential for Liver Injury?
    Mishra P; Chen M
    Gastroenterology; 2017 May; 152(6):1270-1274. PubMed ID: 28327365
    [No Abstract]   [Full Text] [Related]  

  • 40. Ashwagandha as a cause for liver injury.
    Björnsson HK; Björnsson ES; Avula B; Khan IA; Jonasson JG; Ghabril M; Hayashi PH; Navarro V
    Liver Int; 2020 Aug; 40(8):2035-2036. PubMed ID: 32475004
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.